Test-retest reliability of the CSV-1000 contrast test and its relationship to glaucoma therapy

Clicks: 433
ID: 115324
1994
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #9 of 80 articles by views in investigative ophthalmology & visual science

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Visual function in patients with glaucoma, as measured by contrast sensitivity, does improve after beta-blocker therapy. Further, the CSV-1000 is a clinically reliable tool for monitoring these changes.
Reference Key
gn1994investigativetest-retest Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pomerance GN;Evans DW;;
Journal investigative ophthalmology & visual science
Year 1994
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8056510
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine reproducibility of results contrast sensitivity / physiology* aged middle aged Retrospective Studies vision pmid:8056510 g n pomerance d w evans betaxolol / therapeutic use glaucoma open-angle / drug therapy* open-angle / physiopathology levobunolol / therapeutic use timolol / therapeutic use vision disorders / diagnosis* vision tests* ocular

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.